All About Diabetes

Diabetes is a disease in which the body does not produce or properly use insulin. Insulin is a hormone that is needed to convert sugar, starches and other food into energy needed for daily life. The cause of diabetes continues to be a mystery, although both genetics and environmental factors such as obesity and lack of exercise appear to play roles. There are 20.8 million children and adults in the United States, or 7% of the population, who have diabetes. While an estimated 14.6 million have been diagnosed with diabetes, unfortunately, 6.2 million people (or nearly one-third) are unaware that they have the disease. In order to determine whether or not a patient has pre-diabetes or diabetes, health care providers conduct a Fasting Plasma Glucose Test (FPG) or an Oral Glucose Tolerance Test (OGTT). Either test can be used to diagnose pre-diabetes or diabetes. The American Diabetes Association recommends the FPG because it is easier, faster, and less expensive to perform. With the FPG test, a fasting blood glucose level between 100 and 125 mg/dl signals pre-diabetes. A person with a fasting blood glucose level of 126 mg/dl or higher has diabetes. In the OGTT test, a person's blood glucose level is measured after a fast and two hours after drinking a glucose-rich beverage. If the two-hour blood glucose level is between 140 and 199 mg/dl, the person tested has pre-diabetes. If the two-hour blood glucose level is at 200 mg/dl or higher, the person tested has diabetes.

Alternative Methods of Insulin

Alternative Methods of Insulin Sensitivity Assessment in Obese Children and Adolescents

Sophia M Rössner, MD1, Martin Neovius, PhD2, Scott M Montgomery, PhD3,,4,,5, Claude Marcus, MD, PhD6 and Svante Norgren, MD, PhD1

1 Division of Pediatrics, Department of Woman and Child Health, Karolinska Institute, Stockholm, Sweden
2 Department of Medicine, Karolinska Institute, Stockholm, Sweden
3 principal research fellow, Clinical Epidemiology Unit, Karolinska Institute, Stockholm Sweden
4 Clinical Research Centre, Örebro University Hospital, Sweden
5 Department of Primary Care and Social Medicine, Charing Cross Hospital, Imperial College, London, UK
6 National Childhood Obesity Centre, Department for Clinical Science, Intervention and Technology, Division of Pediatrics, Karolinska Institute, Stockholm, Sweden

sophia.rossner@karolinska.se

ABSTRACT

Objective: To validate fasting indices against minimal model analysis of the frequently sampled intravenous glucose tolerance test (FSIVGTT-MMOD) in an obese pediatric population.

Research Design and Methods: FSIVGTT-MMOD results were compared to HOMA-IR and fasting insulin with sample stratified by sex, puberty and Si median in 191 children (82 males; 13.9±2.9y, BMI 36.9±6.2 kg/m2, BMI-SDS 6.1±1.6).

Results: Across pubertal groups correlation coefficients between Si and HOMA-IR ranged from -0.43 to -0.78 in males, and from -0.53 to -0.57 in females (age and BMI adjusted, p<0.05 in all instances). Similar results were seen for fasting insulin. In females the relationship was significantly weaker in more insulin resistant subjects.

Conclusions: The validity of fasting indices in explaining Si was sex dependent, varied with pubertal stage, and in females influenced by degree of insulin sensitivity. In obese pediatric populations we generally discourage the use of fasting indices, although the validity varies within subgroups.

What's the Connection?

 
People with diabetes are twice as likely to develop heart disease than the rest of the population. Among diabetics, heart disease can progress quicker than normal.

Why? Diabetes speeds up hardening of the arteries (also known as atherosclerosis). This can occur when cholesterol levels get too high. You may have heard of LDLs and HDLs. These are the lipoproteins that carry the cholesterol that circulates in your body. LDLs, or low-density proteins, take the cholesterol through the circulatory system to where it is needed. HDL's, or high-densitiy proteins, carry what isn't used back to the liver.

When there is too much cholesterol, the LDLs deposit the left-over cholesterol into the blood vessels. Even though the HDLs try to carry the excess back to the liver, they can't take it all. The extra cholesterol that gets left behind forms plaque on the vessels walls, which makes them less flexible and more narrow. This raises the risk for blood clots, heart attacks and strokes.

Diabetics Should Watch Cholesterol Closely

When someone has diabetes, the glucose in the blood can slow down the LDLs and make them "sticky," which makes the cholesterol build up much faster on the blood vessel walls. That's why people with diabetes have to watch their cholesterol levels more closely and start cholesterol lowering medications sooner than people who do not have diabetes.

 

RELATED LINKS

 

 

 

type 1 diabetes, type1 diabetes, type1 diabetic, diabetes type 1, diabetes type1, type one diabetes, type 1 diabeties, type 1 diabetis, Type 1 Diabetes, 1 diabetes,type 2 diabetes,juvenile diabetes,juvenile onset diabetes, Type 1 diabetes Comprehensive overview covers symptoms, treatment of this lifelong endocrine condition, Type 1 diabetes often strikes children. Learn the symptoms, questions to ask the doctor and how to care for the disease, diabetes, diabetes information, information about diabetes, information on diabetes, diabetes, diabetes type 1, diabetes mellitus, type 1 diabetes, adult onset, juvenile, renal, diabetic neuropathy, high blood sugar, type 1, insulin dependent, insulin, sugar, blood sugar, foot problems, bacterial infections, cholesterol, glaucoma, dictionary, endocrine, glycemia, hyperglycemia, ischemia, polyneuropathy, motor neuropathy, insulin-dependent, non-insulin dependent, hypertension, endocrinology, proteinuria, glucose, blood glucose meters, glucose levels, glucose intolerance, blood glucose, glucose tolerance, fasting blood glucose, blood sugar, blood sugar levels, pancreas, pancreatic, anti hyperglycemic, hypoglycemia, hypoglycemic, obesity, hyperinsulinemia, diabetic diet, kidney disease, ketoacidosis, diabetic coma, insulin coma